NYSE:CTLT

63.07
0.02 (0.03%) 1d
0
DON'T BUY
Catalent

They had a financial problem. Stay away for a while.

biotechnology / pharmaceutical
DON'T BUY
Catalent

Danaher (he owns) or Illumina could buy CTLT, at least that's the talk. Until something happens, he won't buy this.

biotechnology / pharmaceutical
BUY
Catalent

They make the tools that helped Moderna make the Covid vaccine. Roared during the pandemic, then crashed in 2022, but is soaring now. Rumoured that Danaher could take this over.

biotechnology / pharmaceutical
Showing 1 to 3 of 3 entries
  • «
  • 1
  • »

Catalent(CTLT-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Catalent is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Catalent(CTLT-N) Frequently Asked Questions

What is Catalent stock symbol?

Catalent is a American stock, trading under the symbol CTLT-N on the New York Stock Exchange (CTLT). It is usually referred to as NYSE:CTLT or CTLT-N

Is Catalent a buy or a sell?

In the last year, there was no coverage of Catalent published on Stockchase.

Is Catalent a good investment or a top pick?

Catalent was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Catalent.

Why is Catalent stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Catalent worth watching?

In the last year, there was no coverage of Catalent published on Stockchase.

What is Catalent stock price?

On 2024-12-13, Catalent (CTLT-N) stock closed at a price of $63.07.